Introduction
Non-invasive ventilation (NIV) is the first line supportive treatment in case of acute hypercapnic respiratory failure (AHRF). NIV efficacy is continuously monitored using clinical parameters (respiratory frequency, use of accessory respiratory muscles). The assessment of NIV efficacy however usually requires repeated blood gas analysis after 30 or 60 minutes of treatment. A reliable non-invasive technique to continuously monitor PaC02 during NIV could simplify this evaluation and allow an earlier adaptation of ventilator settings.
Objectives
The aim of this study was to assess whether measuring transcutaneous C02 (T p C02) during NIV delivered because of AHRF could be of interest for evaluating PaC02.
Methods
ICU patients requiring NIV for AHRF (PaC02 >42 mmHg) were included in this prospective observational study. T p C02 was measured during a 60-minute NIV treatment using a dedicated auricular sensor and the Sentec monitor (Sentec, Switzerland), connected to the patient 15 minutes before the start of NIV. Blood gas analysis and T c C02 recording were performed before initiating NIV and after 30, 45 and 60 minutes of NIV. The correlation between PaC02 and T p C02 was assessed by linear regression (Spearman) and intraclass correlation coefficient (ICC). The agreement between both techniques was assessed using the Bland and Altmann method for repeated measurements. In a small group of patients undergoing NIV for acute hypercapnic respiratory failure the agreement between T p C02 and PaC02 was very good. This suggests that C02 transcutaneous measurement could be of interest to evaluate the course of PaC02 during NIV.
